Felix Fennemann, MSc ResearcherID:O-2976-2016
Felix.L.Fennemann@radboudumc.nl
Felix Fennemann obtained his Master Degree in Molecular Mechanisms of Disease from the Radboud University Nijmegen and Institute for Molecular Life Sciences in 2016. He discovered his passion for tumor immunology and immunotherapy throughout internships in Nijmegen on dendritic cells and dendritic cell vaccines. He wrote his masterthesis at the Cancer Center Karolinska in Stockholm about modulation of the immunosuppressive tumor microenvironment as a novel anti-cancer therapy.
In his PhD, Felix is working at the intersection of immunology, genetics and chemistry and explores possibilities for the development of smart, personalized anti-cancer therapeutics.
Kayleigh Schouren, MSc
Kayleigh.Schouren@radboudumc.nl
...
Zach Wijfjes, MSc
Zach.Wijfjes@radboudumc.nl
Zach obtained his Master’s degree in Molecular Life Sciences with a specialization in Chemistry of Life at the Radboud University in October 2020. In his first Master’s internship, he focused on synthesizing a compound library of the natural methyltransferase inhibitor Tanshinone I to perform a structure activity relationship study. In his second Master’s internship, he worked on a targeted cathepsin probe to study endosomal pathways in dendritic cells. His interests in organic chemistry and immunology are now combined in his PhD, in which targeted delivery of various bioconjugates to dendritic cells are utilized to study endosomal pathways, and elicit specific antitumor immune responses.
Maren Pfirrmann, MSc
Maren.Pfirrmann@radboudumc.nl
...
Eric van Dinther, BSc
Eric.vanDinther@radboudumc.nl
...
2022
A fluorogenic probe for granzyme B enables in-biopsy evaluation and screening of response to anticancer immunotherapies.
Scott JI, Mendive-Tapia L, Gordon D, Barth ND, Thompson EJ, Cheng Z, Taggart D, Kitamura T, Bravo-Blas A, Roberts EW, Juarez-Jimenez J, Michel J, Piet B, de Vries IJ, Verdoes M, Dawson J, Carragher NO, Connor RAO, Akram AR, Frame M, Serrels A, Vendrell M.
Nat Commun. 2022 May 2;13(1):2366. doi: 10.1038/s41467-022-29691-w.
Efficient targeting of NY-ESO-1 tumor antigen to human cDC1s by lymphotactin results in cross-presentation and antigen-specific T cell expansion.
Le Gall C, Cammarata A, de Haas L, Ramos-Tomillero I, Cuenca-Escalona J, Schouren K, Wijfjes Z, Becker AMD, Bödder J, Dölen Y, de Vries IJM, Figdor CG, Flórez-Grau G, Verdoes M.
J Immunother Cancer. 2022 Apr;10(4):e004309. doi: 10.1136/jitc-2021-004309.
Dictating Phenotype, Function, and Fate of Human T Cells with Co-Stimulatory Antibodies Presented by Filamentous Immune Cell Mimics.
Schluck M, Eggermont LJ, Weiden J, Popelier C, Weiss L, Pilzecker B, Kolder S, Heinemans Anne, Rodriguez Mogeda C, Verdoes M, Figdor CG, Hammink R.
Adv. Therap., 2022 Feb; 5: 2200019. https://doi.org/10.1002/adtp.202200019
Multiscale imaging of therapeutic anti-PD-L1 antibody localization using molecularly defined imaging agents.
Hagemans IM, Wierstra PJ, Steuten K, Molkenboer-Kuenen JDM, van Dalen D, Ter Beest M, van der Schoot JMS, Ilina O, Gotthardt M, Figdor CG, Scheeren FA, Heskamp S,* Verdoes M.*
J Nanobiotechnology. 2022, 20, 64.
2021
Robust Antigen-Specific T Cell Activation within Injectable 3D Synthetic Nanovaccine Depots.
Weiden J, Schluck M, Ioannidis M, van Dinther EAW, Rezaeeyazdi M, Omar F, Steuten J, Voerman D, Tel J, Diken M, Bencherif SA, Figdor CG, Verdoes M.* ACS
Biomater Sci Eng. 2021 , 7, 5622-5632.
Distinct antigen uptake receptors route to the same storage compartments for cross-presentation in dendritic cells.
Ho NI, Camps MG, Garcia-Vallejo JJ, Bos E, Koster AJ, Verdoes M, van Kooyk Y, Ossendorp F.
Immunology. 2021, 164, 494-506.
Enhanced Antitumor Efficacy through an "AND gate" Reactive Oxygen-Species-Dependent pH-Responsive Nanomedicine Approach.
Jäger E, Humajová J, Dölen Y, Kučka J, Jäger A, Konefał R, Pankrác J, Pavlova E, Heizer T, Šefc L, Hrubý M, Figdor CG, Verdoes M.*
Adv Healthc Mater. 2021, 10, e2100304.
Semiflexible Immunobrushes Induce Enhanced T Cell Activation and Expansion.
Hammink R,* Weiden J, Voerman D, Popelier C, Eggermont LJ, Schluck M, Figdor CG, Verdoes M.*
ACS Appl Mater Interfaces. 2021, 13, 16007-16018..
Application of a Highly Selective Cathepsin S Two-step Activity-Based Probe in Multicolor Bio-Orthogonal Correlative Light-Electron Microscopy.
Van Dalen FJ, Bakkum T, van Leeuwen T, Groenewold M, Deu E, Koster AJ, van Kasteren SI, Verdoes M.*
Front Chem. 2021, 8, 628433.
Dual Site-Specific Chemoenzymatic Antibody Fragment Conjugation Using CRISPR-Based Hybridoma Engineering.
Le Gall CM, van der Schoot JMS, Ramos-Tomillero I, Khalily MP, van Dalen FJ, Wijfjes Z, Smeding L, van Dalen D, Cammarata A, Bonger KM, Figdor CG, Scheeren FA, Verdoes M.*
Bioconjug Chem. 2021. 32, 301-310.
Autophagy regulates long-term cross-presentation by murine dendritic cells.
Ho NI, Camps MGM, Verdoes M, Münz C, Ossendorp F.
Eur J Immunol. 2021, 51, 835-847.
2019
An efficient synthesis of a 6″-BODIPY-α-Galactosylceramide probe for monitoring α-Galactosylceramide uptake by cells.
Cheng JMH, Chee SH, Dölen Y, Verdoes M, Timmer MSM, Stocker BL.
Carbohydr Res. 2019. 486:107840.
Functional diversification of hybridoma produced antibodies by CRISPR/HDR genomic engineering.
Johan M.S. van der Schoot, Felix L. Fennemann, Michael Valente, Yusuf Dolen, Iris M. Hagemans, Anouk M.D. Becker, Camille M. Le Gall, Duco van Dalen, Alper Cevirgel, J. Armando C. van Bruggen, Melanie Engelfriet, Marieke F. Fransen, Tomislav Caval, Arthur E.H. Bentlage, Maaike Nederend, Jeanette H.W. Leusen, Albert J.R. Heck, Gestur Vidarsson, Carl G. Figdor, Martijn Verdoes, Ferenc A. Scheeren. Science Advances. 2019 Aug 28, Vol. 5, no. 8, eaaw1822. DOI: 10.1126/sciadv.aaw1822. OPEN ACCESS
! This paper was highlighted on the popular science website NEMO kennislink.
Synthetic Semiflexible and Bioactive Brushes.
Voerman D, Schluck M, Weiden J, Joosten B, Eggermont LJ, van den Eijnde T, Ignacio B, Cambi A, Figdor CG, Kouwer PHJ, Verdoes M, Hammink R, Rowan AE.
Biomacromolecules. 2019 Jun 13. doi: 10.1021/acs.biomac.9b00385. OPEN ACCESS
Biomaterial-Based Activation and Expansion of Tumor-Specific T Cells.
Schluck M, Hammink R, Figdor CG, Verdoes M, Weiden J.
Front Immunol. 2019 May 3;10:931. OPEN ACCESS
Attacking Tumors From All Sides: Personalized Multiplex Vaccines to Tackle Intratumor Heterogeneity.
Fennemann FL, de Vries IJM, Figdor CG, Verdoes M.
Front Immunol. 2019 Apr 16;10:824. OPEN ACCESS
Glutaminyl cyclase is an enzymatic modifier of the CD47- SIRPα axis and a target for cancer immunotherapy.
Logtenberg MEW, Jansen JHM, Raaben M, Toebes M, Franke K, Brandsma AM, Matlung HL, Fauster A, Gomez-Eerland R, Bakker NAM, van der Schot S, Marijt KA, Verdoes M, Haanen JBAG, van den Berg JH, Neefjes J, van den Berg TK, Brummelkamp TR, Leusen JHW, Scheeren FA, Schumacher TN.
Nat Med. 2019 Apr;25(4):612-619. Pubmed
The Alkyne Moiety as a Latent Electrophile in Irreversible Covalent Small Molecule Inhibitors of Cathepsin K.
Mons E, Jansen IDC, Loboda J, van Doodewaerd BR, Hermans J, Verdoes M, van Boeckel CAA, van Veelen PA, Turk B, Turk D, Ovaa H.
J Am Chem Soc. 2019 Feb 27;141(8):3507-3514. Pubmed
The Phosphoinositide Kinase PIKfyve Promotes Cathepsin-S-Mediated Major Histocompatibility Complex Class II Antigen Presentation.
Baranov MV, Bianchi F, Schirmacher A, van Aart MAC, Maassen S, Muntjewerff EM, Dingjan I, Ter Beest M, Verdoes M, Keyser SGL, Bertozzi CR, Diederichsen U, van den Bogaart G.
iScience. 2019 Jan 25;11:160-177. OPEN ACCESS
2018
Molecular Repolarisation of Tumour-Associated Macrophages.
van Dalen FJ, van Stevendaal MHME, Fennemann FL, Verdoes M, Ilina O.
Molecules. 2018 Dec 20;24(1). pii: E9. OPEN ACCESS
Endolysosomal-Escape Nanovaccines through Adjuvant-Induced Tumor Antigen Assembly for Enhanced Effector CD8+ T Cell Activation.
Qiu L, Valente M, Dolen Y, Jäger E, Beest MT, Zheng L, Figdor CG, Verdoes M.
Small. 2018 Apr;14(15):e1703539. Pubmed
Toll-like Receptor Agonist Conjugation: A Chemical Perspective.
Ignacio BJ, Albin TJ, Esser-Kahn AP, Verdoes M.
Bioconjug Chem. 2018 Mar 21;29(3):587-603. Pubmed
2017
Cathepsin B as a potential cystatin M/E target in the mouse hair follicle.
Oortveld MAW, van Vlijmen-Willems IMJJ, Kersten FFJ, Cheng T, Verdoes M, van Erp PEJ, Verbeek S, Reinheckel T, Hendriks WJAJ, Schalkwijk J, Zeeuwen PLJM.
FASEB J. 2017 Jun 8. pii: fj.201700267R. Pubmed
A Rab20-Dependent Membrane Trafficking Pathway Controls M. tuberculosis Replication by Regulating Phagosome Spaciousness and Integrity.
Schnettger L, Rodgers A, Repnik U, Lai RP, Pei G, Verdoes M, Wilkinson RJ, Young DB, Gutierrez MG.
Cell Host Microbe. 2017, 21, 619-628.e5. Pubmed
Live Cell Imaging and Profiling of Cysteine Cathepsin Activity using a Quenched Activity-based Probe.
Edgington-Mitchell, L. E.; Bogyo, M.; Verdoes, M.
Methods Mol. Biol. 2017, 1491, 145-159. Pubmed
2016
Opportunities for immunotherapy in microsatellite instable colorectal cancer.
Westdorp H, Fennemann FL, Weren RD, Bisseling TM, Ligtenberg MJ, Figdor CG, Schreibelt G, Hoogerbrugge N, Wimmers F, de Vries IJ
Cancer Immunol Immunother. 2016. 65(10):1249-59. Pubmed
Legumain is Activated in Macrophages during Pancreatitis.
Edgington-Mitchell LE, Wartmann T, Fleming AK, Gocheva V, van der Linden WA, Withana NP, Verdoes M, Aurelio L, Edgington-Mitchell D, Lieu T, Parker BS, Graham B, Reinheckel T, Furness JB, Joyce JA, Storz P, Halangk W, Bogyo M, Bunnett NW.
Am J Physiol Gastrointest Liver Physiol. 2016. ajpgi.00047.2016. Pubmed
Bifunctional Probes of Cathepsin Protease Activity and pH Reveal Alterations in Endolysosomal pH during Bacterial Infection.
Sanman LE, van der Linden WA, Verdoes M, Bogyo M.
Cell Chem Biol. 2016, 23, 793-804. Pubmed
Dual Modality Activity Based Probes as Molecular Imaging Agents for Vascular Inflammation.
Withana NP, Saito T, Ma X, Garland M, Liu C, Kosuge H, Amsallem M, Verdoes M, Ofori LO, Fischbein M, Arakawa M, Cheng Z, McConnell MV, Bogyo M.
J Nucl Med. 2016, pii: jnumed.115.171553. Pubmed
Non-invasive Imaging of Idiopathic Pulmonary Fibrosis Using Cathepsin Protease Probes.
Withana NP, Ma X, McGuire HM, Verdoes M, van der Linden WA, Ofori LO, Zhang R, Li H, Sanman LE, Wei K, Yao S, Wu P, Li F, Huang H, Xu Z, Wolters PJ, Rosen GD, Collard HR, Zhu Z, Cheng Z, Bogyo M.
Sci Rep. 2016, 6:19755. Pubmed
Labeling of active proteases in fresh-frozen tissues by topical application of quenched activity-based probes.
Withana, N.P.; Garland, M.; Verdoes, M.; Ofori, L.O.; Segal, E.; Bogyo, M.
Nat Protoc. 2016, 11, 184-91. Pubmed
2015
Cysteine Cathepsin Activity Suppresses Osteoclastogenesis of Myeloid-Derived Suppressor Cells in Breast Cancer.
Edgington-Mitchell, L. E.; Rautela, J.; Duivenvoorden, H. M.; Jayatilleke, K. M.; van der Linden, W.; Verdoes, M.; Bogyo, M.; Parker, B. S.
Oncotarget.2015, 6, 27008-22. Pubmed
Design of protease activated optical contrast agents that exploit a latent lysosomotropic effect for use in fluorescence-guided surgery.
Ofori, L. O.; Withana, N. P.; Prestwood, T. R.; Verdoes, M.; Brady, J. J.; Winslow, M. M.; Sorger, J.; Bogyo, M.
ACS Chem Biol. 2015, 10, 1977-88. Pubmed
Regulation of immunoproteasome function in the lung.
Keller, I. E.; Vosyka, O.; Takenaka, S.; Kloß, A.; Dahlmann, B.; Willems, L. I.; Verdoes, M.; Overkleeft, H. S.; Marcos, E.; Adnot, S.; Hauck, S. M.; Ruppert, C.; Günther, A.; Herold, S.; Ohno, S.; Adler, H.; Eickelberg, O.; Meiners, S.
Sci Rep. 2015, 5:10230. Pubmed
Detection of protease activity in cells and animals.
Verdoes, M.; Verhelst, S. H. L.
Biochim Biophys Acta. 2015, pii: S1570-9639(15)00138-7. Pubmed
Design of a highly selective quenched activity-based probe and its application in dual color imaging studies of cathepsin S activity localization.
Oresic Bender, K; Ofori, L.; Van der Linden, W. A.; Mock, E. D.; Data, G.; Chowdhury,S.; Li, H.; Segal, E.; Sanchez Lopez, M.; Ellman, J. A.; Figdor, C. G.; Bogyo, M.; Verdoes, M.
J Am Chem Soc. 2015, 137, 4771-7. Pubmed
! This paper and our related work was highlighted on the popular science website NEMO kennislink.
Detection of Intestinal Cancer by local, topical application of a Quenched Fluorescence Probe for Cysteine Cathepsins.
Segal, E.; Prestwood, T. R.; Van der Linden, W.; Carmi, Y.; Bhattacharya, N.; Verdoes, M.; Engleman, E. G.; Bogyo, M.
Chem Biol. 2015, 22, 148-158. Pubmed
Restoring immunosurveillance by dendritic cell vaccines and manipulation of the tumor microenvironment.
Vasaturo, A.; Verdoes, M.; De Vries, J.; Torensma, R.; Figdor, C. G.
Immunobiology. 2015, 220, 243-248. Pubmed
2014
Exploring dual electrophiles in peptide-based proteasome inhibitors: carbonyls and epoxides.
Xin, B. T.; de Bruin, G.; Verdoes, M.; Filippov, D. V.; van der Marel, G. A.; Overkleeft, H. S.
Org Biomol Chem. 2014, 12, 5710-5718. Pubmed
Assessing subunit dependency of the Plasmodium proteasome using small molecule inhibitors and active site probes.
Li, H.; Van der Linden, W. A.; Verdoes, M.; Florea, B. I.; McAllister, F. E.; Govindaswamy, K.; Elias, J. E.; Bhanot, P.; Overkleeft, H. S.; Bogyo, M. ACS Chem Biol. 2014, 9, 1869-1876. Pubmed
The right touch: Design of artificial antigen-presenting cells to stimulate the immune system.
Van der Weijden, J.; Paulis, L. E.; Verdoes, M.; Van Hest, J. C. M.; Figdor, C. G. Chemical Science. 2014, 5, 3355-3367. Pubmed
2013
An improved quenched fluorescent probe for imaging of cysteine cathepsin activity.
Verdoes, M.*; Oresic Bender, K.; Segal, E.; Van der Linden, W. A.; Salahuddin, S.; Withana, N. P.; Sanman, L. E.; Bogyo, M.* J Am Chem Soc. 2013, 135, 14726-30. Pubmed
Identification of a serine protease inhibitor which causes inclusion vacuole reduction and is lethal to Chlamydia trachomatis.
Gloeckl, S.; Ong, V. A.; Patel, P.; Tyndall, J. D.; Timms, P.; Beagley, K. W.; Allan, J. A.; Armitage, C. W.; Turnbull, L.; Whitchurch, C. B.; Merdanovic, M.; Ehrmann, M.; Powers, J. C.; Oleksyszyn, J.; Verdoes, M.; Bogyo, M.; Huston, W. M. Mol Microbiol. 2013, 89, 676-689. Pubmed
Relative quantification of proteasome activity by activity-based protein profiling and LC-MS/MS.
Li, N.; Kuo, C. L.; Paniagua, G.; van den Elst, H.; Verdoes, M.; Willems, L. I.; Van der Linden, W. A.; Ruben, M.; Van Genderen, E.; Gubbens, J.; van Wezel, G. P.; Overkleeft, H. S.; Florea, B. I. Nat Protoc. 2013, 8, 1155-1168. Pubmed
Functional imaging of legumain in cancer using a new quenched activity-based probe.
Edgington, L. E.; Verdoes, M.; Ortega, A.; Withana, N. P.; Lee, J.; Syed, S.; Bachmann, M. H.; Blum, G.; Bogyo, M.
J Am Chem Soc. 2013, 135, 174-182. Pubmed
Iris Hagemans, MSc
Iris.Hagemans@radboudumc.nl
Iris obtained her BSc in Chemistry at Radboud University Nijmegen and her MSc degree in Chemistry at Leiden University in September 2015. Iris has always been part chemist, part biologist: she took a lot of Molecular Life Science courses in her bachelor’s degree, and in her master’s, she did one organic synthetic internship at the department of Medicinal Chemistry (Leiden University) and one cell biology internship at OncoRay in Dresden, an institute for Research in Radiation Oncology. The ultimate goal was always to combine chemistry and biology, since she believes that when the two come together, that’s where the magic happens.
In her PhD project she is able to combine these two expertises by working on a molecular toolbox for developing novel and improved checkpoint inhibitors. Checkpoint inhibitors block immunosuppressive signals generated by tumor cells. Breakthroughs in the field of these checkpoint inhibitors have even been called the scientific breakthrough of the year 2013. However, the systemic character of this type of therapy has a significant drawback: it elicits auto-immune reactions. The goal of the current project is to generate optimized molecular immune checkpoint-inhibitory approaches.
Jorieke Weiden, MSc Researcher ID: M-5843-2015
Jorieke.Weiden@radboudumc.nl
Jorieke Weiden obtained her Master Degree in Biomedical Sciences from the Radboud University Nijmegen in 2014. Intrigued by cancer and how it interacts with the immune system, she performed an internship on identification of a novel cytogenic subgroup in leukemia in Newcastle-upon-Tyne in the UK and an internship on how neutrophils promote breast cancer dissemination at the Netherlands Cancer Institute in Amsterdam. She joined the department of Tumor immunology for an internship on immunosuppressive pathways in dendritic cell subsets, after which she started her PhD research with Prof. Carl Figdor in 2014 working in the interdisciplinary fields of chemical immunology and immunoengineering. Jorieke is interested in exploiting biomaterial-based scaffolds as tools to locally boost the anti-cancer immune response, specifically dendritic cells and tumor-specific T cells. Jorieke's primary advisor is Prof. Carl Figdor.
Bas van der Schoot, MSc
Bas.vanderSchoot@Radboudumc.nl
Bas was the first to join the Verdoes Lab in 2014 after obtaining his master degree in Science and Business Management at the University of Utrecht. During his Master internships he gained valuable knowledge regarding vaccine design (Crucell) and antibody development (arGEN-X). Bas is interested In the development of novel tools to further advance the field of immunotherapeutics and is currently working on the development and targeting of nanovaccines for cancer immunotherapy. Bas his primary advisor is Prof. Carl Figdor.
Duco van Dalen, BSc
Duco.vanDalen@radboudumc.nl
After an internship in the group of Huib Ovaa, department of Chemical Biology at the Netherlands Cancer Institute (NKI), Duco van Dalen obtained his BsC in organic chemistry at the University of Applied Sciences in Leiden in August 2012.
His life took another direction; he raised the charity ‘Longest Breath’, to create awareness about the dangers and effects of the misuse of asbestos. On March 31st 2013 he began a cycling journey of nine thousand kilometre, from China back to the Netherlands. This all in memory of his father, who died in 2011 as a result of mesothelioma caused by exposure to asbestos (for more information please visit: www.LongestBreath.com).
After two and a half years voluntary work for the charity, he picked up his chemistry career and started working in an analytical lab. But the Biochemistry side kept his interest and he rejoined in 2015 the research group of Huib Ovaa.
End 2016 Martijn Verdoes gave him the opportunity to work for him as technician in his research group. “This opportunity fitted exactly in my dream to live and work in a less busy and more greener environment. To be part of the newly formed research group lead by Martijn Verdoes and work together right at the frontline of the cancer research is highly motivating.” as quoted by Duco.
Olga Ilina, PhD
olga.ilina@radboudumc.nl
Olga received her PhD degree in the Radboud Institute for Molecular Life Sciences. During her PhD she studied how cancer cells invade within the tissue and spread to distant organs. By monitoring cell-cell and cell-stroma interactions using intravital multiphoton microscopy she studied how intracellular adhesion influences the ability of tumor cells to spread and how local tissue geometry modulates cell invasiveness. During her study Olga developed a strong interest in how host cells within the local microenvironment promote tumor growth and how tumor cells evade immune response. Fascinated by the possibility of targeted manipulation of specific immune cells to activate anti-tumor immune response, she joined Verdoes Lab in the Tumor Immunology Department. The goal of her current project is to use cathepsins activity-based probes to eliminate immunosuppressive tumor-associated macrophages.
Iván Ramos-Tomillero, PhD
Ivan.RamosTomillero@radboudumc.nl
Iván Ramos-Tomillero obtained his PhD (2016) in Organic chemistry at the Institute for Research in Biomedicine (IRB/UB), focused on the development of linkers for antibody conjugation. Afterwards he joined for a postdoctoral research at University of Barcelona (2016-2018) for the heat-to-lead optimization of peptide-based drugs. After a one year gap from research working as a scientist project lead for the process development and manufacturing of GMP peptides for clinical trials at ChemConnection, he joined Martijn Verdoes group in 2019 for a new research challenge. His research will be focus on the development of chemical tools like bioconjugates and inhibitors for immunology.
Eliézer Jäger, PhD (2017-2018)
Czech Academy of Sciences fellowship
Eliezer Jäger received his PhD in 2015 at the Faculty of Natural Sciences of the Charles University of Prague, Czech Republic. His PhD studies focused on the synthesis and characterization of biological environmentally responsive (pH, temperature and reactive oxygen species) and non-responsive polymer drug delivery systems (micellar, soluble polymers, NPs). In 2016 he obtained a postdoctoral grant from the Czech Academy of Sciences for starting researchers aiming at the development of multi-responsive dendritic cell-targeted nanovaccines, as well as, tumor “chemical-environment” responsive nanomedicines under supervision of Prof. Carl Figdor and Dr. Martijn Verdoes.
Liping Qiu, PhD (2016)
qiuliping@hnu.edu.cn
Postdoc
Current position:
Assistant Professor
Hunan University · College of Chemistry and Chemical Engineering
Alper Cevirgel (2018)
MMD master student
Liyan Smeding, BSc (2018)
MMD master student
Carl van Heck (2018)
BMW master student
Anouk Becker, BSc (2017)
MMD master student
Valerie Betting, BSc (2017)
MMD master student